Inventor · disambiguated record
Aaron M. Dumas
Also filed as: DUMAS AARON · DUMAS AARON M · DUMAS AARON MICHAEL
5 granted patents·5 pending applications·6 citations·filing 2015–2024
71Inventor score
Files withASTEX THERAPEUTICS LTD3CORCEPT THERAPEUTICS INC2MERCK SHARP & DOHME2RELAY THERAPEUTICS INC2LI HONGMING1
Top patents by PatentIndex Score
10 records- 0184US12077526B2Isoindolinone inhibitors of the MDM2-P53 interaction and process for making themASTEX THERAPEUTICS LTD·Filed 2023·Granted Sep 3, 2024·1 cites·22 claims
- 0279US11603367B2Isoindolinone inhibitors of the MDM2-P53 interaction and process for making themASTEX THERAPEUTICS LTD·Filed 2018·Granted Mar 14, 2023·2 cites·12 claims
- 0376US10472345B2Methods of preparing hydroxylamine derivatives useful in the preparation of anti-infective agentsMERCK SHARP & DOHME·Filed 2017·Granted Nov 12, 2019·1 cites·29 claims
- 0474US12152034B2FGFR inhibitors and methods of making and using the sameRELAY THERAPEUTICS INC·Filed 2021·Granted Nov 26, 2024·1 cites·19 claims
- 0573US10202401B2Process for making tetracyclic heterocycle compoundsMERCK SHARP & DOHME·Filed 2017·Granted Feb 12, 2019·1 cites·3 claims
- 0670US2025074900A1Isoindolinone inhibitors of the mdm2-p53 interaction and process for making themASTEX THERAPEUTICS LTD·Filed 2024·Application pending·0 cites
- 0764US2025011290A1Pyrylium method of preparing pyrimidine cyclohexyl glucocorticoid receptor modulatorsCORCEPT THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0864US2025002462A1Sulfone method of preparing pyrimidine cyclohexyl glucocorticoid receptor modulatorsCORCEPT THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0958US2025243204A1Fgfr inhibitors and methods of making and using the sameRELAY THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1043US2017166586A1Process for making tetracyclic heterocycle compoundsLI HONGMING·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Aaron M. Dumas files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →